Overview

A Study of HRS9531 in Participants With Impaired Kidney Function and Healthy Subjects

Status:
RECRUITING
Trial end date:
2024-07-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess how fast HRS9531 gets into the blood stream and how long it takes the body to remove it in participants with impaired kidney function compared to healthy participants.
Phase:
PHASE1
Details
Lead Sponsor:
Fujian Shengdi Pharmaceutical Co., Ltd.